IL33 and infection: To demonstrate that the increase in ICAM1 expression was responsible for the enhancement in HRV16 infection, MCs were pre-treated with IL-33 for 24 h with and without an anti-ICAM1 antibody or isotype control prior to HRV-16 infection for a further 24 h.